AfaSci Overview
- Year Founded
-
2003
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$2.3M
- Investors
-
3
AfaSci General Information
Description
Developer of peptide and small molecule therapies intended for unmet needs in the fields of pain and neurology. The company's services include pre-clinical tests based on cognitive, sleep monitoring and deprivation, depression, epileptic convulsion, stroke, pharmacokinetics, analgesics, and electrophysiology, enabling scientists to develop tools and therapies based on research.
Contact Information
Website
www.afasci.comCorporate Office
- 2633 Martinez Drive
- Burlingame, CA 94010
- United States
Corporate Office
- 2633 Martinez Drive
- Burlingame, CA 94010
- United States
AfaSci Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Grant | 01-Jan-2023 | $2.3M | Completed | Generating Revenue | ||
| 3. Debt - PPP | 30-Apr-2020 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2019 | $17.7M | Completed | Generating Revenue | ||
| 1. Early Stage VC | Completed | Startup |
AfaSci Patents
AfaSci Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3843731-B1 | Ion channel inhibitory compounds for treating hypersensitive cough | Active | 28-Aug-2018 | ||
| EP-3843731-C0 | Ion channel inhibitory compounds for treating hypersensitive cough | Active | 28-Aug-2018 | ||
| EP-3843731-A1 | Methods of treating hypersensitive cough or itching using ion channel inhibitory compounds | Active | 28-Aug-2018 | ||
| EP-3843731-A4 | Methods of treating hypersensitive cough or itching using ion channel inhibitory compounds | Active | 28-Aug-2018 | ||
| JP-2024096843-A | Methods of treating hypersensitive cough or itching using ion channel inhibitory compounds | Active | 28-Aug-2018 | A61K31/438 |
AfaSci Signals
AfaSci Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institutes of Health | Government | |||
| U.S. Department of Health and Human Services | Government | |||
| Luminor International Management | Venture Capital | Minority |
AfaSci FAQs
-
When was AfaSci founded?
AfaSci was founded in 2003.
-
Where is AfaSci headquartered?
AfaSci is headquartered in Burlingame, CA.
-
What is the size of AfaSci?
AfaSci has 17 total employees.
-
What industry is AfaSci in?
AfaSci’s primary industry is Drug Discovery.
-
Is AfaSci a private or public company?
AfaSci is a Private company.
-
What is AfaSci’s current revenue?
The current revenue for AfaSci is .
-
Who are AfaSci’s investors?
National Institutes of Health, U.S. Department of Health and Human Services, and Luminor International Management have invested in AfaSci.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process